Preoperative chemoradiotherapy with capecitabine with or without temozolomide in patients with locally advanced rectal cancer: A prospective, randomized phase 2 study stratified by MGMT (O6-methylguanine DNA methyltransferase) status: KCSG-CO17-02.

Authors

Chung Ryul Oh

Chung Ryul Oh

Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea

Chung Ryul Oh , Jae Ho Jeong , Ji Sung Lee , Jeong Eun Kim , Sun Young Kim , Tae Won Kim , Jene Choi , Jihun Kim , In Ja Park , Seok-Byung Lim , Jin-hong Park , Jong Hoon Kim , Moon Ki Choi , Yongjun Cha , Ji Yeon Baek , Seung-Hoon Beom , Yong Sang Hong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer - Neo-Adjuvant/Adjuvant

Clinical Trial Registration Number

NCT03156036

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3605)

DOI

10.1200/JCO.2022.40.16_suppl.3605

Abstract #

3605

Poster Bd #

399

Abstract Disclosures